Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0698 CHF | +1.16% | +10.09% | +70.24% |
May. 01 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
Apr. 17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+70.24% | 5.17M | |
+0.10% | 91.42B | |
+2.76% | 41.08B | |
-9.06% | 34.26B | |
+53.61% | 25.27B | |
-9.14% | 12.81B | |
-12.11% | 11.6B | |
-43.61% | 11.42B | |
+5.69% | 9.16B | |
-6.90% | 8.22B |
- Stock Market
- Equities
- POLN Stock
- News Spexis AG
- Transcript : Polyphor AG, 2020 Earnings Call, Mar 05, 2021